Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Research led by scientists at the Ineos Oxford Institute for antimicrobial research at Oxford University has found that wild birds such as ducks and crows living close to humans, for example in cities, are likely to carry bacteria with antimicrobial resistance (AMR). This creates an urgent need for policy makers and health services to consider the different ways antibiotic resistant bacteria can spread outside hospital settings.

City pigeons eating bread on the street © SVPhilon, Getty Images

AMR occurs when disease-causing microbes such as bacteria become resistant to antibiotics that would otherwise kill them. In the UK, an estimated 58,224 people had a severe antibiotic-resistant infection in 2022, and 2,202 died. Globally, AMR was directly responsible for an estimated 1.27 million deaths in 2019, and the World Health Organization has described it as one of the top global public health and development threats.

In a new study published this week in Current Biology (Cell Press), researchers analysed 700 samples of bacteria taken from the guts of 30 species of wild birds across 8 countries.* They looked at Campylobactor jejuni, a common diarrhoea-causing zoonotic bacteria found in birds’ gut microbiomes. Zoonotic diseases are those that can spread between animals and humans.

Using genomic analysis, they studied the diversity of C. jejuni strains, as well as the presence of genes associated with AMR. A novel statistical model was developed to study the relationship between these and various factors including bird behaviour and location.

 

Read the full story on the University of Oxford website.

Similar stories

KEMRI renews collaboration with Wellcome Trust and University of Oxford

The Kenya Medical Research Institute (KEMRI) has signed a seven-year Memorandum of Agreement with Wellcome Trust, a UK charitable organization, and the University of Oxford, on Wednesday 27 November 2024, at the KEMRI Headquarters, Nairobi. Under this collaboration, Wellcome has awarded GBP 91 million (KES 15 billion) to support research over the next 7 years.